EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

PNPLA3, Obesity, and Heavy Alcohol Use in Cirrhosis Patients May Exert a Synergistic Increase Hepatocellular Carcinoma Risk

Aaron P Thrift, Fasiha Kanwal, Hyeyeun Lim, Hao Duong, Yanhong Liu, Amit G Singal, Saira Khaderi, Sumeet K Asrani, Christopher I Amos, Hashem B El-Serag

Clinical Gastroenterology and Hepatology · 2024

DOI: 10.1016/j.cgh.2024.04.006 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical Gastroenterology and Hepatology, 2024. Verfasst von Aaron P Thrift und 9 weiteren Autor:innen. Beteiligte Einrichtung: Section of Epidemiology and Population Sciences, Department of Medicine, Baylor College of Medicine, Houston, Texas; Dan L Duncan Comprehensive Cance…. Hauptthemen laut MEDLINE: Alcohol Drinking, Carcinoma, Hepatocellular, Liver Cirrhosis, Liver Neoplasms. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND & AIMS: In patients with cirrhosis, continued heavy alcohol consumption and obesity may increase risk of hepatocellular carcinoma (HCC). We examined whether germline susceptibility to hepatic steatosis not only independently predisposes to HCC but may also act synergistically with other risk factors. METHODS: We analyzed data from 1911 patients in 2 multicenter prospective cohort studies in the United States. We classified patients according to alcohol consumption (current heavy vs not current heavy), obesity (body mass index ≥30 vs

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alcohol DrinkingCarcinoma, HepatocellularLiver CirrhosisLiver NeoplasmsObesityPhospholipases A2, Calcium-IndependentAgedFemaleHumansMaleMiddle AgedAcyltransferasesGenetic Predisposition to DiseaseLipaseMembrane ProteinsProspective StudiesRisk AssessmentRisk FactorsUnited States

Stichwörter der Autor:innen

Cohort StudyEpidemiologyMASLDRisk StratificationTexas HCC Consortium

Substanzen

AcyltransferasesLipaseMembrane ProteinsPhospholipases A2, Calcium-IndependentPNPLA3 protein, human

Autor:innen und Institutionen

  • Section of Epidemiology and Population Sciences, Department of Medicine, Baylor College of Medicine, Houston, Texas; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.
  • Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, Houston, Texas; Veterans Affairs Health Services Research and Development Service Center for Innovations in Quality, Effect…
  • Section of Epidemiology and Population Sciences, Department of Medicine, Baylor College of Medicine, Houston, Texas.
  • Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, Houston, Texas.
  • Division of Digestive and Liver Diseases, Department of Medicine, UT Southwestern Medical Center, Dallas, Texas.
  • Baylor University Medical Center, Dallas, Texas.

Förderung

  • NCI NIH HHS
  • NIH HHS
  • NIDDK NIH HHS
  • NIEHS NIH HHS

Zitieren

APA

Thrift, A. P., Kanwal, F., Lim, H., Duong, H., Liu, Y., Singal, A. G., Khaderi, S., Asrani, S. K., Amos, C. I., & El-Serag, H. B. (2024). PNPLA3, Obesity, and Heavy Alcohol Use in Cirrhosis Patients May Exert a Synergistic Increase Hepatocellular Carcinoma Risk. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2024.04.006

Vancouver

Thrift AP, Kanwal F, Lim H, Duong H, Liu Y, Singal AG, et al. PNPLA3, Obesity, and Heavy Alcohol Use in Cirrhosis Patients May Exert a Synergistic Increase Hepatocellular Carcinoma Risk. Clinical Gastroenterology and Hepatology. 2024. doi:10.1016/j.cgh.2024.04.006

BibTeX
@article{Thrift2024,
  author = {Thrift, Aaron P and Kanwal, Fasiha and Lim, Hyeyeun and Duong, Hao and Liu, Yanhong and Singal, Amit G and Khaderi, Saira and Asrani, Sumeet K and Amos, Christopher I and El-Serag, Hashem B},
  title = {PNPLA3, Obesity, and Heavy Alcohol Use in Cirrhosis Patients May Exert a Synergistic Increase Hepatocellular Carcinoma Risk},
  journal = {Clinical Gastroenterology and Hepatology},
  year = {2024},
  doi = {10.1016/j.cgh.2024.04.006}
}
Kostenlos starten →